Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Jiangsu Hansoh Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 18613

Product Synopsis

Jiangsu Hansoh Pharmaceutical Co., Ltd. Product Pipeline Review 2014

Summary

Global Markets Directs, Jiangsu Hansoh Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the Jiangsu Hansoh Pharmaceutical Co., Ltd.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Jiangsu Hansoh Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Jiangsu Hansoh Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Jiangsu Hansoh Pharmaceutical Co., Ltd.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Jiangsu Hansoh Pharmaceutical Co., Ltd.s pipeline products

Reasons to buy

Evaluate Jiangsu Hansoh Pharmaceutical Co., Ltd.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Jiangsu Hansoh Pharmaceutical Co., Ltd. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Jiangsu Hansoh Pharmaceutical Co., Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Jiangsu Hansoh Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Jiangsu Hansoh Pharmaceutical Co., Ltd.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Jiangsu Hansoh Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Jiangsu Hansoh Pharmaceutical Co., Ltd. Snapshot 4
Jiangsu Hansoh Pharmaceutical Co., Ltd. Overview 4
Key Information 4
Key Facts 4
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Research and Development Overview 5
Key Therapeutic Areas 5
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products Glance 9
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Early Stage Pipeline Products 11
Discovery Products/Combination Treatment Modalities 11
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Drug Profiles 12
desvenlafaxine succinate SR 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
iloperidone 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
azilsartan 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
cafusertib hydrochloride 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecule for Respiratory Disease 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Analysis 17
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products by Target 17
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products by Route of Administration 18
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products by Molecule Type 19
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products by Mechanism of Action 20
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Locations And Subsidiaries 21
Head Office 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables

Jiangsu Hansoh Pharmaceutical Co., Ltd., Key Information 4
Jiangsu Hansoh Pharmaceutical Co., Ltd., Key Facts 4
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline by Indication, 2014 6
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline by Stage of Development, 2014 7
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Monotherapy Products in Pipeline, 2014 8
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Phase II, 2014 9
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Phase I, 2014 10
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Discovery, 2014 11
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline by Target, 2014 17
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline by Route of Administration, 2014 18
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline by Molecule Type, 2014 19
Jiangsu Hansoh Pharmaceutical Co., Ltd.- Pipeline Products by Mechanism of Action, 2014 20

List of Figures

Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014 6
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 7
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 8
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2014 17
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014 18
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014 19
Jiangsu Hansoh Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014 20

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing